HPR160 Analysis of the Time Spent by AIFA Committees for the Assessment of New Drugs: Impact of the Application of Managed Entry Agreements
Abstract
Authors
P Brambilla A Torriani D Lidonnici R Ravasio P Raimondo
P Brambilla A Torriani D Lidonnici R Ravasio P Raimondo
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now